Loading…
Loading grant details…
| Funder | Swedish Research Council |
|---|---|
| Recipient Organization | Lund University |
| Country | Sweden |
| Start Date | Jul 01, 2024 |
| End Date | Jun 30, 2027 |
| Duration | 1,094 days |
| Number of Grantees | 1 |
| Roles | Principal Investigator |
| Data Source | Swedish Research Council |
| Grant ID | 2024-00228_VR |
Pregnant mothers with substance use disorders pose a high risk for developmental disorders in their offspring.While there is therapeutic potential of psychedelic compounds, such as lysergic acid diethylamide, through serotonin signaling for maternal health, the potential adverse outcomes on neurodevelopment resulting from fetal exposure to psychedelics are not completely understood.The choroid plexus, the main producer of cerebrospinal fluid (CSF) containing growth factors crucial for brain development, exhibits the highest expression of the serotonin 5HT2C receptors in the developing brain.
How maternal exposure to psychedelics affects the fetal choroid plexus, is currently unknown.In this project, the effects of maternal administration of psychedelics on the activation of fetal choroid plexus and the CSF proteome, along with resulting hippocampal development in offspring, will be characterized.Advanced two-photon microscopy will be used to capture choroid plexus activity, and proteomics techniques will determine secreted CSF composition upon maternal exposure of psychedelics.
Immunohistochemical procedures and behaviors studies will be employed to determine the effect on hippocampal development.Careful characterization of the interactions between maternal psychedelic exposure, choroid plexus activity, and fetal hippocampal development will contribute to a more comprehensive understanding about potential adverse outcomes of psychedelic exposure on fetal brain development.
Lund University
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant